PulseData
PulseData is a healthcare AI company that revolutionizes population health management by providing clinically-validated predictive insights to identify, predict, and intervene in chronic diseases. Their patented AI platform helps payers, providers, and value-based care organizations transform data into precise predictive models, enabling early detection and targeted interventions. This leads to improved patient outcomes, reduced costs, and enhanced workflow efficiency by directing the right patients to the right programs at the right time. Key solutions include better chronic disease diagnosis, admission risk prediction, improved HCC accuracy, and prevention of avoidable ED visits, all delivered to the point of care.
PulseData
PulseData is a healthcare AI company that revolutionizes population health management by providing clinically-validated predictive insights to identify, predict, and intervene in chronic diseases. Their patented AI platform helps payers, providers, and value-based care organizations transform data into precise predictive models, enabling early detection and targeted interventions. This leads to improved patient outcomes, reduced costs, and enhanced workflow efficiency by directing the right patients to the right programs at the right time. Key solutions include better chronic disease diagnosis, admission risk prediction, improved HCC accuracy, and prevention of avoidable ED visits, all delivered to the point of care.
TL;DR
Sector: Healthcare AI / predictive analytics
Core product: Clinically-validated predictive models and data intelligence platform for chronic/cardiorenal disease
Customers: Payers, providers, and value-based care organizations (includes U.S. Department of Veterans Affairs and Vytal)
Founded by: Hai Po Sun and Teddy Cha
Employees: Approximately 26
Total funding: USD 19,700,000 (last round: Series A on 2021-04-19)
Company Overview
Problem Domain
Population health management, chronic disease detection and progression prediction (focus on cardiorenal / chronic kidney disease).
Industry
Healthcare AI
Funding Track Record
Latest documented round is Series A on 2021-04-19; public sources list Bain Capital Private Equity and Two Bear Capital as investors
Investor Signal
“Has institutional backers including Bain Capital Private Equity, Two Bear Capital, and earlier seed investors such as Homebrew”